These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 32152553)

  • 1. Physiology of gangliosides and the role of antiganglioside antibodies in human diseases.
    Cutillo G; Saariaho AH; Meri S
    Cell Mol Immunol; 2020 Apr; 17(4):313-322. PubMed ID: 32152553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiganglioside antibodies--their pathophysiological effects on Guillain-Barré syndrome and variants].
    Kaida K; Kusunoki S
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(1):29-39. PubMed ID: 21372511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research.
    Kusunoki S; Kaida K; Ueda M
    Biochim Biophys Acta; 2008 Mar; 1780(3):441-4. PubMed ID: 17976386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review.
    Kaida K; Kusunoki S
    J Neuroimmunol; 2010 Jun; 223(1-2):5-12. PubMed ID: 20172612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions.
    Shahrizaila N; Yuki N
    Expert Rev Neurother; 2011 Sep; 11(9):1305-13. PubMed ID: 21864076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.
    Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guillain-Barré and Fisher syndromes: update on the pathophysiological role of antiganglioside antibodies].
    Kaida K
    Rinsho Shinkeigaku; 2012; 52(11):914-6. PubMed ID: 23196466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodies.
    Wang DJ; Boltz DA; McElhaney J; McCullers JA; Webby RJ; Webster RG
    Influenza Other Respir Viruses; 2012 May; 6(3):159-66. PubMed ID: 21955390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Guillain-Barré syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides.
    Alborzian Deh Sheikh A; Gomaa S; Li X; Routledge M; Saigoh K; Numoto N; Angata T; Hitomi Y; Takematsu H; Tsuiji M; Ito N; Kusunoki S; Tsubata T
    J Autoimmun; 2021 Jan; 116():102571. PubMed ID: 33223341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiganglioside complex antibody].
    Hongo Y; Kaida K
    Nihon Rinsho; 2013 May; 71(5):839-44. PubMed ID: 23777091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to Glycolipids in Guillain-Barré Syndrome, Miller Fisher Syndrome and Related Autoimmune Neurological Diseases.
    Kusunoki S
    Adv Neurobiol; 2023; 29():479-495. PubMed ID: 36255685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
    Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
    J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the Role of Anti-ganglioside Antibodies in Guillain-Barré Syndrome: an Animal Model Approach.
    Asthana P; Vong JS; Kumar G; Chang RC; Zhang G; Sheikh KA; Ma CH
    Mol Neurobiol; 2016 Sep; 53(7):4981-91. PubMed ID: 26374552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
    Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
    Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.
    Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S
    J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM; Moran AP
    J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.